AI algorithm accurately IDs two life-threatening heart conditions
Mar 14, 2022
The model can distinguish between hypertrophic cardiomyopathy and cardiac amyloidosis using ultrasound videos.
Lipid profiling can predict future risk for type 2 diabetes, CVD
Mar 11, 2022
In the highest-risk groups for T2D and CVD, significantly altered lipidome compositions affected 167 and 157 lipid species, respectively.
Meta-analysis shows prevalence of statin intolerance Is low
Feb 16, 2022
The prevalence of statin intolerance was 9.1% overall; significant associations were seen for age, female gender, Asian and Black race, obesity and diabetes mellitus.
Monitoring blood pressure at home more acceptable to adults
Sep 27, 2021
For adults with elevated blood pressure, monitoring it at home is more acceptable than at a clinic or kiosk or using a 24-hour ambulatory blood pressure monitor, according to a study presented at the American...
ADA: Bempedoic acid cuts MACE in statin-intolerant patients
Jun 26, 2023
Significant risk reduction was observed in the primary end point of composite of cardiovascular death nonfatal myocardial infarction, nonfatal stroke, coronary revascularization.
High AI-ECG-AF risk score tied to worse cognition, cognitive decline
May 11, 2022
A high probability of atrial fibrillation by AI-ECG-AF score correlated with cerebral infarcts on MRI.
Daily multivitamin does not cut cancer incidence in older adults
Mar 18, 2022
A same randomized two-by-two factorial trial shows that cocoa extract did not significantly reduce total cardiovascular events in older adults.
Ultraprocessed food increases risk for death with type 2 diabetes
Aug 02, 2023
The findings were seen for all-cause death and cardiovascular mortality.
US deaths drop in 2022, but still higher than prepandemic levels
Dec 15, 2022
COVID-19 will remain the third-largest killer for 2022, behind heart disease and cancer, even with the reduced numbers.
Data elements, definitions for COVID-19 complications detailed
Jun 27, 2022
The clinical lexicon presents data elements related to cardiovascular and noncardiovascular complications of COVID-19.